Delivery Order SPE2DB22D2206-SPE2DB24FKH45

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,449.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,481,761 Simvastatin 40 mg tablets. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. This is a firm fixed-price delivery order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, valued at $1,486.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Simvastatin 40 mg tablets, a drug used to treat high cholesterol. This is a Firm Fixed Price Delivery Order contract, with a completion date of September 26, 2022. The contract was not set aside for any specific business type....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,498.71, is for the delivery of 4,564,978,299 tablets of Simvastatin 40 mg, with a performance period through June 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,804.76 firm fixed-price delivery order is for the supply of 4,566,205,526 units of the generic drug Simvastatin 40mg tablets. The award has an ultimate completion date of October 28, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,326.92, is for the delivery of Simvastatin 40 mg tablets in quantities of 1,000. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 30, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL24M, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,418.34 firm fixed-price delivery order is for the supply of 4,563,653,743 units of Simvastatin 40 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,201.04, is for the delivery of 4,564,732,939 tablets of Simvastatin 40 mg, a common cholesterol medication. The contract type is a Delivery Order under a Firm Fixed Price pricing structure and has a completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,763.52, is a Delivery Order for the supply of 4,565,047,099 tablets of Simvastatin 40 mg. The award has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $15,066.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for 4,554,895,614 units of Simvastatin 40 mg tablets, a cardiovascular medication. The contract has a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself...
This federal contract award, valued at $2,400.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of 4,563,970,555 units of Simvastatin 40 mg tablets. The award has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger indefinite delivery contract (IDC)...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKH45
    Delivery Order

This federal contract award, valued at $2,065.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,784,187 units of Simvastatin 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of September 13, 2024. It is not designated as a set-aside contract. AmerisourceBergen, through its Corporate Office Division, will provide these critical prescription drugs to support military treatment facilities and other federal healthcare programs. The company has been awarded several Indefinite Delivery Contracts (IDCs) by the DLA and Department of Justice, valued up to $999,999,999 and $750,000 respectively, for the comprehensive supply of pharmaceutical and medical commodities to the U.S. government.

Generated 12/12/24, 10:13 AM